Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands

A Iraji, M Khoshneviszadeh, O Firuzi… - Bioorganic …, 2020 - Elsevier
Alzheimer's Disease (AD) is a progressive neurodegenerative disorder that effects 50 million
people worldwide. In this review, AD pathology and the development of novel therapeutic …

Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases

D Vanda, P Zajdel, M Soural - European Journal of Medicinal Chemistry, 2019 - Elsevier
This article provides an overview of compounds based on imidazo [1, 2-a] pyridine, imidazo
[1, 5-a] pyridine, imidazo [4, 5-b] pyridine and imidazo [4, 5-c] pyridine scaffolds, which act as …

Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease

K Rajasekhar, M Chakrabarti… - Chemical …, 2015 - pubs.rsc.org
Amyloidogenesis has been implicated in a broad spectrum of diseases in which amyloid
protein is invariably misfolded and deposited in cells and organs. Alzheimer's disease is one …

Synthesis of Functionalized 3‐(1H‐Isochromen)‐chromones via Ag2O‐Catalyzed Cascade Cyclization Reaction of o‐Hydroxyarylenaminones with o …

M Zhang, Z Liu, L Chen, D Liu, Y Sun… - Advanced Synthesis …, 2022 - Wiley Online Library
A silver‐catalyzed protocol for the synthesis of 3‐(1H‐isochromen)‐chromones is described.
The method involves an initial 6‐endo‐dig cyclization of o‐alkynylbenzaldehydes and …

Coumarin linked heterocyclic hybrids: a promising approach to develop multi target drugs for Alzheimer's disease

A Husain, K Al Balushi, MJ Akhtar, SA Khan - Journal of Molecular Structure, 2021 - Elsevier
Alzheimer's disease (AD) is a major progressive and perplexing cortical degenerative
disease of the brain in the elderly. It contributes to a significant socioeconomic burden on …

Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating …

A Iraji, O Firuzi, M Khoshneviszadeh… - European journal of …, 2017 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder known for the presence of
amyloid beta plaques resulting from the sequential action of β-secretase and γ-secretase on …

Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for …

SK Yusufzai, MS Khan, O Sulaiman, H Osman… - Chemistry Central …, 2018 - Springer
Coumarins are the phytochemicals, which belong to the family of benzopyrone, that display
interesting pharmacological properties. Several natural, synthetic and semisynthetic …

Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1, 2, 4-triazine scaffold containing pendant phenoxy methyl-1, 2, 3-triazole: Design …

M Yazdani, N Edraki, R Badri, M Khoshneviszadeh… - Bioorganic …, 2019 - Elsevier
Alzheimer's disease (AD) is a complex neurological disorder with diverse underlying
pathological processes. Several lines of evidence suggest that BACE1 is a key enzyme in …

Ru (ii) catalyzed chelation assisted C (sp 2)–H bond functionalization along with concomitant (4+ 2) annulation

A Sarkar, M Saha, AR Das - Organic & Biomolecular Chemistry, 2023 - pubs.rsc.org
Efficacious protocols have been established to synthesize a structurally privileged Π-
extended coumarin-fused pyridone nucleus by activating the vinylic C (sp2)–H bond of …

Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy

H Zhang, Y Peng, L Zhuo, Y Wang, G Zeng… - European Journal of …, 2022 - Elsevier
Due to the hugely important roles of neurotransmitter acetylcholine (ACh) and amyloid-β
(Aβ) in the pathogenesis of Alzheimer's disease (AD), the development of multi-target …